Boston Legacy FC announced a multi-year partnership with Collegium Pharmaceutical (COLL), naming the company an Official Partner of Boston Legacy FC. Through this collaboration, Boston Legacy FC and Collegium are working together to ensure that the club’s home games are welcoming and sensory-inclusive for all fans. As part of the partnership, the Collegium Sensory Room will be available at Gillette Stadium and Centreville Bank Stadium in 2026, and White Stadium beginning in 2027, for all Boston Legacy FC home matches. The dedicated space will provide a quieter, more secure environment for guests who may need a break from the visual and auditory stimulation of a matchday experience. The room will be outfitted to support comfort and regulation, helping ensure a positive and inclusive guest experience for all fans.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COLL:
- Collegium Pharmaceutical price target raised to $58 from $55 at Truist
- Collegium Pharmaceutical management to meet with Truist
- Collegium price target lowered to $56 from $58 at Barclays
- Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright
- Collegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target